VERVE-101 is a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol.
Does VERVE-101 permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol?
VERVE-101 is a novel CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and lower LDL-cholesterol.
Absolute Event Rate: 0% vs 0%
Just over two decades ago, a new member of the secretory subtilase family, neural apoptosis-regulated convertase 1 (NARC-1), now known as proprotein convertase subtilisin/kexin type 9 (PCSK9), w...
Hooper et al. (Sat,) reported a other. VERVE-101 is a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol.